Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Equity (2020 - 2025)

Goldenwell Biotech (GWLL) has disclosed Return on Equity for 6 consecutive years, with 0.25% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 1094.0% year-over-year to 0.25%, compared with a TTM value of 0.25% through Sep 2025, up 1094.0%, and an annual FY2024 reading of 7.02%, down 620.0% over the prior year.
  • Return on Equity was 0.25% for Q3 2025 at Goldenwell Biotech, down from 0.06% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.73% in Q4 2024 and bottomed at 11.19% in Q3 2024.
  • Average Return on Equity over 5 years is 2.24%, with a median of 0.39% recorded in 2022.
  • The sharpest move saw Return on Equity crashed -785bps in 2023, then soared 1094bps in 2025.
  • Year by year, Return on Equity stood at 0.37% in 2021, then plummeted by -1102bps to 4.49% in 2022, then surged by 73bps to 1.23% in 2023, then surged by 322bps to 2.73% in 2024, then plummeted by -109bps to 0.25% in 2025.
  • Business Quant data shows Return on Equity for GWLL at 0.25% in Q3 2025, 0.06% in Q2 2025, and 0.64% in Q1 2025.